
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is a global technology leader in robotic-assisted, minimally invasive surgery with over 10,000 da Vinci systems placed worldwide. The company's strong financial performance, including an operating margin of 38.9%, and increased procedure volume in the US and internationally, are key indicators of its continued success and potential for future growth. The recent launch of a new Dv5 system, along with continued innovation and expansion in the ecosystem, further demonstrates Intuitive's commitment to improving surgical outcomes and driving adoption of their technology.
Bears say
Intuitive Surgical is facing pressure from peers in the medical technology industry, resulting in a compressed valuation multiple of 50x for its FY27 adjusted forecast. While the company continues to see strong global demand for its da Vinci system, especially in emerging markets, its growth rate has only slightly exceeded expectations. Additionally, both the SP and Ion systems are experiencing converging utilization rates, which could limit potential for further growth.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares